{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T13:13:11Z","timestamp":1792761191431,"version":"4.5.0"},"reference-count":76,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T00:00:00Z","timestamp":1759017600000},"content-version":"am","delay-in-days":301,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1U01MH130700"],"award-info":[{"award-number":["1U01MH130700"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1R01NS126397"],"award-info":[{"award-number":["1R01NS126397"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmn.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Chemical Biology"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.cbpa.2024.102532","type":"journal-article","created":{"date-parts":[[2024,9,28]],"date-time":"2024-09-28T19:15:30Z","timestamp":1727550930000},"page":"102532","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Engineering novel adeno-associated viruses (AAVs) for improved delivery in the nervous system"],"prefix":"10.1016","volume":"83","author":[{"given":"Ana D.","family":"Carneiro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David V.","family":"Schaffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cbpa.2024.102532_bib1","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s40259-017-0234-5","article-title":"Adeno-associated virus (AAV) as a vector for gene therapy","volume":"31","author":"Naso","year":"2017","journal-title":"BioDrugs"},{"key":"10.1016\/j.cbpa.2024.102532_bib2","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/s41573-019-0012-9","article-title":"Adeno-associated virus vector as a platform for gene therapy delivery","volume":"18","author":"Wang","year":"2019","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.cbpa.2024.102532_bib3","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/s41576-019-0205-4","article-title":"Engineering adeno-associated virus vectors for gene therapy","volume":"21","author":"Li","year":"2020","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.cbpa.2024.102532_bib4","article-title":"AAV targeting of glial cell types in the central and peripheral nervous system and relevance to human gene therapy","volume":"13","author":"O'Carroll","year":"2021","journal-title":"Front Mol Neurosci"},{"key":"10.1016\/j.cbpa.2024.102532_bib5","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0140-6736(17)31868-8","article-title":"Efficacy and safety of voretigene neparvovec (AAV2-hRPE65v2) in patients with RPE65-mediated inherited retinal dystrophy: a randomised, controlled, open-label, phase 3 trial","volume":"390","author":"Russell","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.cbpa.2024.102532_bib6","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1056\/NEJMoa1706198","article-title":"Single-Dose gene-replacement therapy for spinal muscular atrophy","volume":"377","author":"Mendell","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cbpa.2024.102532_bib7","doi-asserted-by":"crossref","unstructured":"Ghanekar SD, Kuo S-H, Staffetti JS, Zesiewicz TA: Current and emerging treatment modalities for spinocerebellar ataxias. [date unknown], doi:10.1080\/14737175.2022.2029703.","DOI":"10.1080\/14737175.2022.2029703"},{"key":"10.1016\/j.cbpa.2024.102532_bib8","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1016\/j.ymthe.2023.07.013","article-title":"Novel MECP2 gene therapy is effective in a multicenter study using two mouse models of Rett syndrome and is safe in non-human primates","volume":"31","author":"Powers","year":"2023","journal-title":"Mol Ther"},{"key":"10.1016\/j.cbpa.2024.102532_bib9","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1089\/hum.2009.182","article-title":"Prevalence of serum IgG and neutralizing factors against adeno-associated virus (AAV) types 1, 2, 5, 6, 8, and 9 in the healthy population: implications for gene therapy using AAV vectors","volume":"21","author":"Boutin","year":"2010","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.cbpa.2024.102532_bib10","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.omtm.2022.02.011","article-title":"Testing preexisting antibodies prior to AAV gene transfer therapy: rationale, lessons and future considerations","volume":"25","author":"Mendell","year":"2022","journal-title":"Mol Ther Methods Clin Dev"},{"key":"10.1016\/j.cbpa.2024.102532_bib11","doi-asserted-by":"crossref","first-page":"9111","DOI":"10.1128\/JVI.00622-13","article-title":"Capsid antibodies to different adeno-associated virus serotypes bind common regions","volume":"87","author":"Gurda","year":"2013","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.cbpa.2024.102532_bib12","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.ymthe.2022.11.015","article-title":"Targeting the central nervous system in lysosomal storage diseases: strategies to deliver therapeutics across the blood-brain barrier","volume":"31","author":"Critchley","year":"2023","journal-title":"Mol Ther"},{"key":"10.1016\/j.cbpa.2024.102532_bib13","doi-asserted-by":"crossref","DOI":"10.3390\/brainsci8090177","article-title":"Neurodegenerative diseases: regenerative mechanisms and novel therapeutic approaches","volume":"8","author":"Hussain","year":"2018","journal-title":"Brain Sci"},{"key":"10.1016\/j.cbpa.2024.102532_bib14","article-title":"Evaluating the transduction efficiency of systemically delivered AAV vectors in the rat nervous system","volume":"17","author":"Yang","year":"2023","journal-title":"Front Neurosci"},{"key":"10.1016\/j.cbpa.2024.102532_bib15","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2018.00887","article-title":"Strategies for targeted delivery to the peripheral nerve","volume":"12","author":"Langert","year":"2018","journal-title":"Front Neurosci"},{"key":"10.1016\/j.cbpa.2024.102532_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.devcel.2023.01.002","article-title":"Characterization of the structure and control of the blood-nerve barrier identifies avenues for therapeutic delivery","author":"Malong","year":"2023","journal-title":"Dev Cell"},{"key":"10.1016\/j.cbpa.2024.102532_bib17","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2015.00036","article-title":"Systemic AAVrh10 provides higher transgene expression than AAV9 in the brain and the spinal cord of neonatal mice","volume":"8","author":"Tanguy","year":"2015","journal-title":"Front Mol Neurosci"},{"key":"10.1016\/j.cbpa.2024.102532_bib18","first-page":"59","article-title":"Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes","volume":"271","author":"Foust","year":"2008","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.cbpa.2024.102532_bib19","first-page":"1","article-title":"Efficacy of AAV serotypes to target Schwann cells after intrathecal and intravenous delivery","volume":"11","author":"Kagiava","year":"2021","journal-title":"Sci Reports"},{"key":"10.1016\/j.cbpa.2024.102532_bib20","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2014.00081","article-title":"Intravenous AAV9 efficiently transduces myenteric neurons in neonate and juvenile mice","volume":"7","author":"Gombash","year":"2014","journal-title":"Front Mol Neurosci"},{"key":"10.1016\/j.cbpa.2024.102532_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0361-9230(00)00230-6","article-title":"The blood\u2013nerve barrier: enzymes, transporters and receptors\u2014a comparison with the blood\u2013brain barrier","volume":"52","author":"Allt","year":"2000","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.cbpa.2024.102532_bib22","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0301-0082(94)90002-7","article-title":"Transport properties of vertebrate blood-nerve barrier: comparison with blood-brain barrier","volume":"43","author":"Wadhwani","year":"1994","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.cbpa.2024.102532_bib23","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/nbt1073","article-title":"Adeno-associated virus serotype 8 efficiently delivers genes to muscle and heart","volume":"23","author":"Wang","year":"2005","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.cbpa.2024.102532_bib24","article-title":"Intraganglionic AAV6 results in efficient and long-term gene transfer to peripheral sensory nervous system in adult rats","volume":"8","author":"Yu","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.cbpa.2024.102532_bib25","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.omtm.2019.11.006","article-title":"rAAV2-Retro enables extensive and high-efficient transduction of lower motor neurons following intramuscular injection","volume":"17","author":"Chen","year":"2020","journal-title":"Mol Ther Methods Clin Dev"},{"key":"10.1016\/j.cbpa.2024.102532_bib26","doi-asserted-by":"crossref","first-page":"3277","DOI":"10.1016\/j.ymthe.2023.09.018","article-title":"Intrathecal delivery of AAV-NDNF ameliorates disease progression of ALS mice","volume":"31","author":"Cheng","year":"2023","journal-title":"Mol Ther"},{"key":"10.1016\/j.cbpa.2024.102532_bib27","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.ejpn.2022.12.003","article-title":"Inflammatory markers in cerebrospinal fluid of paediatric spinal muscular atrophy patients receiving nusinersen treatment","volume":"42","author":"Scheijmans","year":"2023","journal-title":"Eur J Paediatr Neurol"},{"key":"10.1016\/j.cbpa.2024.102532_sref28","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2022.988914","article-title":"Routes of administration for adeno-associated viruses carrying gene therapies for brain diseases","volume":"15","author":"Zhou","year":"2022","journal-title":"Front Mol Neurosci"},{"key":"10.1016\/j.cbpa.2024.102532_bib29","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.omtm.2021.09.017","article-title":"Seven-year follow-up of durability and safety of AAV CNS gene therapy for a lysosomal storage disorder in a large animal","volume":"23","author":"Marc\u00f3","year":"2021","journal-title":"Mol Ther Methods Clin Dev"},{"key":"10.1016\/j.cbpa.2024.102532_bib30","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1126\/science.1068452","article-title":"Neurofibromas in NF1: Schwann cell origin and role of tumor environment","volume":"296","author":"Zhu","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.cbpa.2024.102532_bib31","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/978-1-4939-3271-9_10","article-title":"Controlling AAV tropism in the nervous system with natural and engineered capsids","volume":"1382","author":"Castle","year":"2016","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.cbpa.2024.102532_bib32","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nature16465","article-title":"An essential receptor for adeno-associated virus infection","volume":"530","author":"Pillay","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.cbpa.2024.102532_bib33","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1038\/s41434-021-00243-z","article-title":"Intracellular trafficking of adeno-associated virus (AAV) vectors: challenges and future directions","volume":"28","author":"Riyad","year":"2021","journal-title":"Gene Ther"},{"key":"10.1016\/j.cbpa.2024.102532_bib34","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.virol.2008.08.027","article-title":"Tyrosine phosphorylation of AAV2 vectors and its consequences on viral intracellular trafficking and transgene expression","volume":"381","author":"Zhong","year":"2008","journal-title":"Virology"},{"key":"10.1016\/j.cbpa.2024.102532_bib35","doi-asserted-by":"crossref","first-page":"7827","DOI":"10.1073\/pnas.0802866105","article-title":"Next generation of adeno-associated virus 2 vectors: point mutations in tyrosines lead to high-efficiency transduction at lower doses","volume":"105","author":"Zhong","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.cbpa.2024.102532_bib36","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/mt.2010.234","article-title":"Novel properties of tyrosine-mutant AAV2 vectors in the mouse retina","volume":"19","author":"Petrs-Silva","year":"2011","journal-title":"Mol Ther"},{"key":"10.1016\/j.cbpa.2024.102532_bib37","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.omtm.2018.03.004","article-title":"A\u00a0rationally engineered capsid variant of AAV9 for systemic CNS-directed and peripheral tissue-detargeted gene delivery in neonates","volume":"9","author":"Wang","year":"2018","journal-title":"Mol Ther Methods Clin Dev"},{"key":"10.1016\/j.cbpa.2024.102532_bib38","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1038\/12491","article-title":"Genetic capsid modifications allow efficient re-targeting of adeno-associated virus type 2","volume":"5","author":"Girod","year":"1999","journal-title":"Nat Med"},{"key":"10.1016\/j.cbpa.2024.102532_bib39","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1038\/s41551-022-00938-7","article-title":"Variants of the adeno-associated virus serotype 9 with enhanced penetration of the blood\u2013brain barrier in rodents and primates","volume":"6","author":"Yao","year":"2022","journal-title":"Nat Biomed Eng"},{"key":"10.1016\/j.cbpa.2024.102532_bib40","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/nbt1182","article-title":"Directed evolution of adeno-associated virus yields enhanced gene delivery vectors","volume":"24","author":"Maheshri","year":"2006","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.cbpa.2024.102532_bib41","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1038\/mt.2008.167","article-title":"DNA shuffling of adeno-associated virus yields functionally diverse viral progeny","volume":"16","author":"Koerber","year":"2008","journal-title":"Mol Ther"},{"key":"10.1016\/j.cbpa.2024.102532_bib42","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1038\/mt.2016.84","article-title":"In\u00a0vivo selection yields AAV-B1 capsid for central nervous system and muscle gene therapy","volume":"24","author":"Choudhury","year":"2016","journal-title":"Mol Ther"},{"key":"10.1016\/j.cbpa.2024.102532_bib43","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1038\/nn.4593","article-title":"Engineered AAVs for efficient noninvasive gene delivery to the central and peripheral nervous systems","volume":"20","author":"Chan","year":"2017","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.cbpa.2024.102532_bib44","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.135112","article-title":"In\u00a0vivo-directed evolution of adeno-associated virus in the primate retina","volume":"5","author":"Byrne","year":"2020","journal-title":"JCI insight"},{"key":"10.1016\/j.cbpa.2024.102532_bib45","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3005708","article-title":"In\u00a0vivo-directed evolution of a new adeno-associated virus for therapeutic outer retinal gene delivery from the vitreous","volume":"5","author":"Dalkara","year":"2013","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.cbpa.2024.102532_bib46","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.64175","article-title":"Scaavengr, a transcriptome-based pipeline for quantitative ranking of engineered aavs with single-cell resolution","volume":"10","author":"\u00d6zt\u00fcrk","year":"2021","journal-title":"Elife"},{"key":"10.1016\/j.cbpa.2024.102532_bib47","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.neuron.2016.09.021","article-title":"A\u00a0designer AAV variant permits efficient retrograde access to projection neurons","volume":"92","author":"Tervo","year":"2016","journal-title":"Neuron"},{"key":"10.1016\/j.cbpa.2024.102532_bib48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ncomms4075","article-title":"Drawing a high-resolution functional map of adeno-associated virus capsid by massively parallel sequencing","volume":"5","author":"Adachi","year":"2014","journal-title":"Nat Commun"},{"key":"10.1016\/j.cbpa.2024.102532_bib49","doi-asserted-by":"crossref","first-page":"27053","DOI":"10.1073\/pnas.1910061116","article-title":"A\u00a0systematic capsid evolution approach performed in\u00a0vivo for the design of AAV vectors with tailored properties and tropism","volume":"116","author":"Davidsson","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.cbpa.2024.102532_bib50","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/nbt.3440","article-title":"Cre-dependent selection yields AAV variants for widespread gene transfer to the adult brain","volume":"34","author":"Deverman","year":"2016","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.cbpa.2024.102532_bib51","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.ymthe.2017.09.006","article-title":"In\u00a0vivo selection of a computationally designed SCHEMA AAV library yields a novel variant for infection of adult neural stem cells in the SVZ","volume":"26","author":"Ojala","year":"2018","journal-title":"Mol Ther"},{"key":"10.1016\/j.cbpa.2024.102532_sref52","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1016\/j.neuron.2022.05.003","article-title":"Engineered AAVs for non-invasive gene delivery to rodent and non-human primate nervous systems ll NeuroResource Engineered AAVs for non-invasive gene delivery to rodent and non-human primate nervous systems","volume":"110","author":"Chen","year":"2022","journal-title":"Neuron"},{"key":"10.1016\/j.cbpa.2024.102532_bib53","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1038\/s41592-023-01896-x","article-title":"Hardwiring tissue-specific AAV transduction in mice through engineered receptor expression","volume":"20","author":"Zengel","year":"2023","journal-title":"Nat Methods"},{"key":"10.1016\/j.cbpa.2024.102532_sref54","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1038\/s41565-023-01419-x","article-title":"Adeno-associated viral vectors for functional intravenous gene transfer throughout the non-human primate brain","volume":"18","author":"Chuapoco","year":"2023","journal-title":"Nat Nanotechnol"},{"key":"10.1016\/j.cbpa.2024.102532_bib55","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.omtm.2020.12.006","article-title":"Rapid evolution of blood-brain-barrier-penetrating AAV capsids by RNA-driven biopanning","volume":"20","author":"Nonnenmacher","year":"2021","journal-title":"Mol Ther Methods Clin Dev"},{"key":"10.1016\/j.cbpa.2024.102532_bib56","doi-asserted-by":"crossref","first-page":"4919","DOI":"10.1016\/j.cell.2021.08.028","article-title":"Directed evolution of a family of AAV capsid variants enabling potent muscle-directed gene delivery across species","volume":"184","author":"Tabebordbar","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.cbpa.2024.102532_sref57","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.medj.2022.11.002","article-title":"Systemic administration of novel engineered AAV capsids facilitates enhanced transgene expression in the macaque CNS","volume":"4","author":"Stanton","year":"2023","journal-title":"Med"},{"key":"10.1016\/j.cbpa.2024.102532_bib58","series-title":"Protein building blocks preserved by recombination","author":"Voigt","year":"2002"},{"key":"10.1016\/j.cbpa.2024.102532_bib59","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1038\/gt.2015.74","article-title":"AAV ancestral reconstruction library enables selection of broadly infectious viral variants","volume":"22","author":"Santiago-Ortiz","year":"2015","journal-title":"Gene Ther"},{"key":"10.1016\/j.cbpa.2024.102532_bib60","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/j.celrep.2015.07.019","article-title":"In silico reconstruction of the viral evolutionary lineage yields a potent gene therapy vector","volume":"12","author":"Zinn","year":"2015","journal-title":"Cell Rep"},{"key":"10.1016\/j.cbpa.2024.102532_bib61","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1126\/science.aaw2900","article-title":"Comprehensive AAV capsid fitness landscape reveals a viral gene and enables machine-guided design","volume":"366","author":"Ogden","year":"2019","journal-title":"Science (80-)"},{"key":"10.1016\/j.cbpa.2024.102532_bib62","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1038\/s41587-020-00793-4","article-title":"Deep diversification of an AAV capsid protein by machine learning","volume":"39","author":"Bryant","year":"2021","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.cbpa.2024.102532_bib63","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0225206","article-title":"Delivering genes across the blood-brain barrier: LY6A, a novel cellular receptor for AAV-PHP.B capsids","volume":"14","author":"Huang","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.cbpa.2024.102532_sref64","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3002112","article-title":"Targeting AAV vectors to the central nervous system by engineering capsid\u2013receptor interactions that enable crossing of the blood\u2013brain barrier","volume":"21","author":"Huang","year":"2023","journal-title":"PLoS Biol"},{"key":"10.1016\/j.cbpa.2024.102532_sref65","doi-asserted-by":"crossref","first-page":"3786","DOI":"10.1126\/sciadv.adj3786","article-title":"Optimal trade-off control in machine learning\u2013based library design, with application to adeno-associated virus (AAV) for gene therapy","volume":"10","author":"Zhu","year":"2024","journal-title":"Sci Adv"},{"key":"10.1016\/j.cbpa.2024.102532_bib66","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2021.809118","article-title":"Gene therapy advances: a meta-analysis of AAV usage in clinical settings","volume":"8","author":"Au","year":"2022","journal-title":"Front Med"},{"key":"10.1016\/j.cbpa.2024.102532_bib67","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.jconrel.2023.01.067","article-title":"AAV vectors applied to the treatment of CNS disorders: clinical status and challenges","volume":"355","author":"Kang","year":"2023","journal-title":"J\u00a0Contr Release"},{"key":"10.1016\/j.cbpa.2024.102532_bib68","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12864-020-07227-0","article-title":"A\u00a0comprehensive evaluation of long read error correction methods","volume":"21","author":"Zhang","year":"2020","journal-title":"BMC Genom"},{"key":"10.1016\/j.cbpa.2024.102532_bib69","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.omtn.2021.06.026","article-title":"Genome-wide activation screens to increase adeno-associated virus production","volume":"26","author":"Barnes","year":"2021","journal-title":"Mol Ther Nucleic Acids"},{"key":"10.1016\/j.cbpa.2024.102532_bib70","article-title":"Evolving membrane-associated accessory protein variants for improved adeno-associated virus production","author":"Schieferecke","year":"2023","journal-title":"Mol Ther"},{"key":"10.1016\/j.cbpa.2024.102532_bib71","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1038\/s41593-019-0431-2","article-title":"Targeting neuronal and glial cell types with synthetic promoter AAVs in mice, non-human primates and humans","volume":"22","author":"J\u00fcttner","year":"2019","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.cbpa.2024.102532_bib72","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/978-1-4939-3271-9_6","article-title":"Tissue-Specific promoters in the CNS","volume":"1382","author":"K\u00fcgler","year":"2016","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.cbpa.2024.102532_bib73","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.113348","article-title":"An ultra-compact promoter drives widespread neuronal expression in mouse and monkey brains","volume":"42","author":"Wang","year":"2023","journal-title":"Cell Rep"},{"key":"10.1016\/j.cbpa.2024.102532_sref74","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1080\/14712598.2022.2060737","article-title":"Addressing high dose AAV toxicity \u2013 \u2018one and done\u2019 or \u2018slower and lower\u2019?","volume":"22","author":"Kishimoto","year":"2022","journal-title":"Expet Opin Biol Ther"},{"key":"10.1016\/j.cbpa.2024.102532_bib75","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/S1474-4422(23)00313-7","article-title":"Safety and efficacy of gene replacement therapy for X-linked myotubular myopathy (ASPIRO): a multinational, open-label, dose-escalation trial","volume":"22","author":"Shieh","year":"2023","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.cbpa.2024.102532_bib76","doi-asserted-by":"crossref","first-page":"9188","DOI":"10.1126\/scitranslmed.aba9188","article-title":"MicroRNA-mediated inhibition\u00a0of transgene expression reduces dorsal root ganglion toxicity by AAV vectors in primates","volume":"12","author":"Hordeaux","year":"2020","journal-title":"Sci Transl Med"}],"container-title":["Current Opinion in Chemical Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S136759312400108X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S136759312400108X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,23]],"date-time":"2024-11-23T13:06:37Z","timestamp":1732367197000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S136759312400108X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":76,"alternative-id":["S136759312400108X"],"URL":"https:\/\/doi.org\/10.1016\/j.cbpa.2024.102532","relation":{},"ISSN":["1367-5931"],"issn-type":[{"value":"1367-5931","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Engineering novel adeno-associated viruses (AAVs) for improved delivery in the nervous system","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Chemical Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cbpa.2024.102532","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102532"}}